BCL9L overexpression is positively correlated with poor overall survival in hepatocellular carcinoma patients, and silencing BCL9L, but not BCL9, reduced Wnt signaling, and suppressed cell growth and induced apoptosis of Wnt-inactive hepatocellular carcinoma cells40. The gene discussed is BCL9; the disease is hepatocellular carcinoma.